Biomx (PHGE) Stock Price
Biomx Price
For Biomx, the net margin of 7,330.3% is down versus 21,132.1% a few years ago. The consensus 12-month price target for Biomx is 168.30 USD, about 121,768.2% above where the stock trades today. Of 8 analysts, 7 rate the stock a buy — an overall Buy consensus. The stock trades about 5% above its 52-week low.
Biomx stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Biomx over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Biomx stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Biomx's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Biomx Price |
|---|---|
| 9/2/2026 | 0.14 USD |
| 9/1/2026 | 0.14 USD |
| 8/31/2026 | 0.14 USD |
| 8/28/2026 | 0.14 USD |
| 8/27/2026 | 0.13 USD |
| 8/26/2026 | 0.13 USD |
| 8/25/2026 | 0.14 USD |
| 8/24/2026 | 0.14 USD |
| 8/21/2026 | 0.14 USD |
| 8/20/2026 | 0.14 USD |
| 8/19/2026 | 0.14 USD |
| 8/18/2026 | 0.14 USD |
| 8/17/2026 | 0.14 USD |
| 8/14/2026 | 0.15 USD |
| 8/13/2026 | 0.16 USD |
| 8/12/2026 | 0.15 USD |
| 8/10/2026 | 0.17 USD |
| 8/7/2026 | 0.17 USD |
| 8/6/2026 | 0.16 USD |
| 8/5/2026 | 0.17 USD |
| 8/4/2026 | 0.18 USD |
| 8/3/2026 | 0.19 USD |
| 7/31/2026 | 0.18 USD |
| 7/30/2026 | 0.19 USD |
| 7/29/2026 | 0.18 USD |
| 7/27/2026 | 0.19 USD |
| 7/23/2026 | 0.20 USD |
| 7/22/2026 | 0.20 USD |
| 7/21/2026 | 0.21 USD |
| 7/20/2026 | 0.20 USD |
Biomx Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Biomx Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEM USD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM USD |
| EBITB USD |
| EBIT MARGIN% |
| NET INCOMEM USD |
| NET INCOME GROWTH% |
| SHARESB |
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | 2027e | 2028e | 2029e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | 23.00 | 57.00 | 13.00 | 20.00 |
| – | – | – | – | – | – | – | – | – | – | – | 147.83 | -77.19 | 53.85 |
| – | – | – | – | – | – | – | – | – | – | -8.70 | -3.51 | -15.38 | -10.00 |
| -2.00 | -2.00 | -2.00 | -2.00 | -2.00 | -2.00 | -2.00 | -2.00 | -1.00 | -2.00 | -2.00 | -2.00 | -2.00 | -2.00 |
| – | -0.01 | – | -0.02 | -0.03 | -0.04 | -0.03 | -0.03 | -0.04 | -0.04 | -9.54 | -9.80 | -7.45 | -51.44 |
| – | – | – | – | – | – | – | – | – | – | -41,473.91 | -17,192.98 | -57,315.38 | -257,200.00 |
| -1.00 | -6.00 | – | -20.00 | -30.00 | -36.00 | -28.00 | -26.00 | -17.00 | -36.00 | -8.00 | -9.00 | -6.00 | -48.00 |
| – | 500.00 | – | – | 50.00 | 20.00 | -22.22 | -7.14 | -34.62 | 111.76 | -77.78 | 12.50 | -33.33 | 700.00 |
| 1.63 | 1.63 | – | – | – | – | – | – | 0.01 | 1.63 | 1.63 | 1.63 | 1.63 | 1.63 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Biomx generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Biomx retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Biomx's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Biomx has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Biomx's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Biomx stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Biomx Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Biomx business model & stock analysis
Biomx Employees
3 Years
5 Years
10 Years
25 Years
Max
Details
Biomx Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Biomx historical P/E ratio, EBIT multiple, and P/S ratio
Biomx annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Biomx shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Biomx stock splits
Current Biomx forecasts and price targets in September 2026
Analyst Price Targets 2026Biomx Analyst Rating Actions
| Date | Firm | Action | Rating | Reliability |
|---|---|---|---|---|
| 3/9/2026 | Downgrade | BuyNeutral | – | |
| 11/26/2025 | Maintained | Buy | – | |
| 11/25/2025 | Maintained | Buy | – | |
| 8/20/2025 | Maintained | Buy | – | |
| 5/16/2025 | Maintained | Buy | – | |
| 4/4/2025 | Maintained | Buy | – | |
| 4/1/2025 | Maintained | Buy | – | |
| 1/10/2025 | Maintained | Buy | – | |
| 1/8/2025 | Maintained | Buy | – | |
| 1/8/2025 | Maintained | Buy | – |
Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.
Biomx Earnings Estimates & Surprises
| Date | EPS estimate | EPS Actual | Revenue Estimate | Price reaction | Quarterly report |
|---|---|---|---|---|---|
| 8/13/2025 | -0.33USD | - | 0.00USD | - | 2025 Q2 |
| 11/12/2024 | -0.51USD | - | 0.00USD | - | 2024 Q3 |
| 11/7/2023 | -0.19USD | - | 0.00USD | - | 2023 Q3 |
| 8/8/2023 | -0.20USD | - | 0.00USD | - | 2023 Q2 |
| 7/6/2023 | -0.24USD | - | 0.00USD | - | 2022 Q4 |
| 5/9/2023 | -0.20USD | - | 0.00USD | - | 2023 Q1 |
| 11/9/2022 | -0.23USD | - | 0.00USD | - | 2022 Q3 |
| 8/10/2022 | -0.28USD | - | 0.00USD | - | 2022 Q2 |
| 5/11/2022 | -0.30USD | - | 0.00USD | - | 2022 Q1 |
| 3/30/2022 | -0.29USD | - | 761,249.00USD | - | 2021 Q4 |
Biomx shareholder structure
| % | Name |
|---|---|
163.01359% | |
162.96137% | |
121.17856% | |
77.31523% | |
58.36444% | |
28.10458% |
Biomx Beneficial Ownership Filings (SEC 13D/G)
| Stake | Holder | Filing |
|---|---|---|
20.40% | SEC ↗ | |
19.99% | SEC ↗ | |
19.99% | SEC ↗ | |
16.57% | SEC ↗ | |
16.57% | SEC ↗ | |
16.57% | SEC ↗ | |
11.60% | SEC ↗ | |
11.60% | SEC ↗ | |
9.99% | SEC ↗ | |
9.99% | SEC ↗ |
Biomx Executives and Management Board
12 members · avg. age 58 · 33 % women
Mr. Jonathan Solomon (46)
Chief Executive Officer, Director · since 2019
1.04 M USD
Management
Dr. Merav Bassan (57)
Chief Development Officer
Mr. Assaf Oron (48)
Chief Business Officer
Ms. Marina Wolfson (39)
Chief Financial Officer
Ms. Anat Primovich
Corporate Project Manager · since 2022
Board of Directors
Dr. Russell Greig (70)
Independent Chairman of the Board
Dr. Alan Moses (75)
Independent Director
Dr. Jesse Goodman (72)
Director
Mr. Jonathan Leff (55)
Director
Mr. Gregory Merril (58)
Director
Ms. Susan Blum (52)
Independent Director
Frequently asked questions about Biomx
Analysts currently set an average price target of 168.30 USD for the Biomx stock (median: 168.30 USD), implying +121,768.2 % versus the latest price. The consensus is based on 8 analyst ratings.
8 analysts currently rate the Biomx stock: 7 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Biomx to generate revenue of 23.55 M USD and earnings per share of -0.01 USD.
Converted at the current exchange rate, the Biomx share trades at 0.12 EUR (0.14 USD).
No history available for Biomx.
The expected revenue of Biomx is 23.55 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Biomx is -8.95 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Biomx is currently -25.17. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Biomx stock.
The price-to-sales ratio (P/S) of Biomx is currently 9.57. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Biomx stock.
The Eulerpool Quality Score for Biomx is 2/10.
The ISIN of Biomx is US09090D5095. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Biomx is A2P9A0. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Biomx is PHGE. The ticker symbol is used to trade Biomx shares on the stock exchange.
Biomx paid dividends every year for the past 0 years.
Biomx is assigned to the 'Health' sector.
The dividends of Biomx are distributed in USD.
Biomx stock
Biomx Peer Group
Biomx Ticker
All fundamentals and in-depth analysis of Biomx
Our stock analysis for Biomx stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Biomx. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.